Carpmaels & Ransford has again been ranked as a leading patent firm in the areas of Pharma and biotechnology, Medical technology, Chemistry, Digital communication and computer technology, and Electronics in this year’s edition of the JUVE Patent UK rankings.

The firm was also recommended in the Solicitor firms in litigation category.

12 Partners and Senior Associates were named as recommended individuals in the rankings, including Ian Kirby, David Wilson, Camilla Balleny, Harvey Adams, Stephen Duffield, Hugh Goodfellow, Simon Llewellyn, Cameron Marshall, Edward Oates, Gary Small, James Warner, and Daniel Wise.

The JUVE Patent UK recognises UK intellectual property firms and practitioners with a leading reputation in their fields. The extensive research process includes interviews with clients, academics, lawyers, and judges.

JUVE includes the following quotes about the firm in the litigation category:

“For many years now, the patent litigation practice at Carpmaels & Ransford has enjoyed a strong position in the London market, which extends Europe-wide when it comes to both patent prosecution and litigation in the pharma and biotech fields.”

“Only few other London litigation practices have a presence in pharma proceedings on the side of originator companies to rival that of Carpmaels. What is more, the teams at Powell Gilbert, Allen & Overy and Hogan Lovells have not been able to shine with a mixed approach of litigators and patent attorneys. When it comes to EPO oppositions and appeals, Carpmaels plays in the top European league with Hoffmann Eitle and Vossius & Partner.”

“Now that a 2022 start of the UPC is on the horizon, Carpmaels has several aces up its sleeve. The highly litigation-experienced European patent attorneys, although mostly UK nationals, can represent cases before the UPC.”

Click here to read the full write up.